Eric Devroe
Chief Operating Officer at Acrivon Therapeutics · 6 reported transactions in 1 company · latest trade Jan 13, 2026
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +20.0%, S&P 500 +7.4% over the same days.
Their trades
Bought | Jan 13, 2026 | Jan 13, 2026 close $1.70 → Oct 29, 2026 close $1.76. S&P 500 +11.3% over the same days. |
BoughtAcrivon Therapeutics
$17.2K
Jan 13, 2026 close $1.70 → Oct 29, 2026 close $1.76. S&P 500 +11.3% over the same days.